One week to go 🙌 We're looking forward to welcoming you at CPhI WW next October 8-10 in Milan at our booth No. 4A41 😊. Engage with our experts and learn how we can support your projects with end-to-end solutions. Our sustainable commitment is not limited just to the way we produce and distribute our products but includes all the business activities we run. For this reason, this year we will attend CPHI Milan 2024 with the same booth we built for the previous edition of the event. The stand is made entirely from eco-sustainable materials—white honeycomb cardboard and Linoleum®—and is therefore 100% recyclable. But it doesn't stop there. The entire life cycle of the setup is designed to be environmentally sustainable, from its conception, design, production, and shipping, to its use and disposal or reuse. This approach views the exhibition not as a standalone experience but as part of a broader flow that reflects the brand's commitment to sustainable choices and strategies. We can’t wait to see you and offer you a delicious aperitivo in true Milanese style. Don’t miss the chance to taste the wine and delicious Italian food provided directly by our team! Schedule a meeting today to meet our team of experts and discuss your project with us: [email protected] Learn more about ICE Pharma offering: https://www.icepharma.com/ #ICEPharma #CPHI #CPHIMilan #pharma #sustainability
Chi siamo
ICE, standing for Industria Chimica Emiliana, was founded in Northern Italy in 1949 and is now headquartered in Reggio Emilia. Since its establishment ICE has grown organically and through acquisition to develop a globally integrated business that produces ingredients for the Pharma industry. Thanks to this vertically integrated model, ICE has become a leader in bile-related products manufacturing. ICE’s most relevant production is the Ursodeoxycholic Acid (UDCA), that is an Active Pharmaceuticals Ingredient (API) used to manufacture medicines for the majority of liver disease, being effective for treating gallstones as well as for oncological conditions. On top of UDCA production, ICE is also committed to enhance the production and quality for almost 20 other APIs that are currently manufactured in our sites. ICE is constantly striving towards product portfolio innovation by developing new processes and investing in state-of-the-art technologies and continued staff training; and thus its R&D Laboratories are strongly engaged in the development of New Chemical Entities based on bile acids, some of which are currently in Phase III development. ICE has developed, to sustain its global reach, a strong Quality and Regulatory structure, that support business and operations in maintaining both constant quality output and glocal regulations compliance. API’s production is fully compliant with cGMP standards (EU, US, Japan) in all the company sites. While striving to further enhance its business, ICE also wants to maintain the core values that mostly contributed to its success: - Quality in Everything We Do - Safety Above All - Treat Everybody with Respect - Innovation for our Clients and Patients ICE currently have almost 1.000 employees working in 11 facilities across the world (EMEA, LATAM, NAFTA, APAC). Since 2019 ICE is backed by Advent International, one of the main PE funds in the world, and is now aiming to achieve new great goals in the coming few years.
- Sito Web
-
https://www.icepharma.com/
Link esterno per ICE Pharma
- Settore
- Fabbricazione di prodotti farmaceutici
- Dimensioni dell’azienda
- 1001 - 5000 dipendenti
- Sede principale
- Reggio Emilia
- Tipo
- Società privata non quotata
- Data di fondazione
- 1949
Località
Dipendenti presso ICE Pharma
-
Clay Stobaugh
Strategic Advisor
-
Kim Watson
Professor of Structural Biochemistry, School of Biological Sciences, University of Reading
-
Nicola Palumbo
Group Chief Accounting Officer at ICE Pharma | Finance Director | M&A | International Tax | PE portfolio | Chartered Accountant | Chartered Auditor
-
Paolo Sacco
Responsabile di laboratorio ricerca e sviluppo presso Industria Chimica Emiliana S.p.A.
Aggiornamenti
-
Just two weeks to go! 🙌 We're looking forward to welcoming you at CPhI WW next October 8-10 in Milan at our booth 4A41, to explore the company’s cutting-edge innovations, network with industry experts and discover the potential of our offerings To drive long-term value and strengthen business resilience, the company has built its sustainability strategy around four core priorities: Fighting Illness through Product Innovation, Caring for People, Accelerating Sustainable Operations, and Building Strong Relationships. These pillars integrate essential environmental, social, and governance (ESG) aspects, shaping the company's value creation and impact throughout its supply chain. Our strategy will also create value by contributing holistically to both a healthier society and the environment. In alignment with this commitment, ICE Pharma is bringing its sustainability vision to CPhI Milan 2024 with a fully recyclable booth. This year, we are excited to present the same stand, fully embracing the principles of “Reduce, Reuse, Recycle.” Recycling is considered a final step, following the reduction and reuse of materials. The stand is constructed entirely from eco-sustainable materials—white honeycomb cardboard and Linoleum®—making it 100% recyclable. Schedule a meeting today: [email protected] Learn more about ICE Pharma offering: https://www.icepharma.com/ #ICEPharma #CPHI #CPHIMilan #pharma #sustainability
-
-
On September 10th, we had the honour of hosting Gianluigi Benedetti, the Ambassador of Italy to Japan, and Francesco Paolo Cannito, the Counsellor and Head of the Economic & Commercial Office, at our ICE Japan site in Iwaki. 🌏 In a productive business meeting with our leadership team, Mr. Benedetti emphasized the significance of the 150 years of bilateral relations between Italy and Japan, dating back to the Meiji Era. He highlighted how our collaboration, as two G7 nations, has grown stronger than ever and holds the potential to drive unprecedented results through mutual understanding and dedicated teamwork. We also had the opportunity to showcase our state-of-the-art plant, certified for supply to the Japanese, US, European, and Chinese markets, along with our patented technology. A special thank you to ICE Japan General Manager, Dr. Kailash Sharma, whose strong relationship-building efforts made this visit possible. We’re grateful to everyone who contributed to making this experience an invaluable success! 🙏 #ItalyJapanRelations #BusinessCollaboration #Innovation #Leadership #GlobalPartnership
-
-
ICE Pharma will be at CPhI Worldwide 2024, in Milan, from 8th to 10th October. Booth 4A41. ICE Pharma is at the forefront of biliary acids research, enabling the transformation of bile, a natural by-product of animals, into active ingredients for some of the world’s most essential medicines. ICE Pharma fulfils a unique need for pharmaceutical and biotech industries with its ingredients to help them treat their patients. What sets us apart is our cutting-edge R&D capabilities that, alongside or academic partners, allow us to break new ground together. We believe our sustainability strategy will support the long-term resilience of the business and our supply chain, while providing a source of fulfilment for our employees and enabling our customers to continue developing and providing cures and treatments for hepatic and neurological diseases, and other conditions that respond to biliary acid-based therapies. Keep an eye on our posts! Schedule a meeting today: [email protected] Learn more about ICE Pharma offering: https://www.icepharma.com/ #ICEPharma #CPHI #CPHIMilan #pharma #sustainability
-
-
ICE Pharma is glad to announce its participation as an exhibitor at CPhI Worldwide 2024, in Milan, from 8th to 10th October. ICE Pharma invites all attendees to explore its offerings at Booth 4A41. ICE Pharma, a multinational company and leader in the creation of drug treatments derived from biliary acids, offers an extensive portfolio of products and services for the pharmaceutical and healthcare markets. We have a unique range of bile acid products and are a leading global integrated producer of Ursodeoxycholic acid (UDCA). Our services business provides also contract manufacturing for solid and liquid finished dosage forms. Schedule a meeting today: [email protected] Learn more about ICE Pharma offering: https://www.icepharma.com/ #ICEPharma #CPHI #CPHIMilan #pharma
-
-
We are glad to announce that ICE Pharma will be participating in CPhI Worldwide, taking place in Milan, October 8th – 10th, 2024. Join us at Stand 4A41 in the API Hall. Schedule your meeting with our team now to discuss potential collaborations and explore our latest offerings. To arrange a meeting, please send an email to: [email protected]
-
-
Did you know that ICE Pharma has 16 active patents filed in more than 200 countries and we employ more than 50 highly qualified team members at our R&D centres worldwide, covering a wide spectrum of technologies. Our R&D teams have particularly strong expertise in three key areas: - New bile acid derivatives and plant-based alternatives (Uk and New Zealand) - Animal bile derivatives from different sources (Italy and India) - Carbohydrate chemistry (UK). to know more visit our site: https://www.icepharma.com/
-
-
ICE Pharma is glad to announce our participation at CPHI China 2024! From June 19-21, visit us at Booth E5 C72 as we unveil our latest pharmaceutical innovations, discuss industry trends, and explore collaborative opportunities. We can't wait to connect with fellow professionals and industry leaders at this premier event. See you in Shanghai! #ICEPharma #CPHIShanghai2024 #PharmaceuticalInnovation #IndustryNetworking
-
-
Innovative Approach to Multiple Sclerosis Treatment Groundbreaking research has unveiled the potential of bile acid supplements, especially Tauroursodeoxycholic acid (TUDCA), in treating Multiple Sclerosis (MS). These supplements could play a crucial role in reducing neuroinflammation and promoting neuroprotection by influencing the activity of astrocytes and microglia. Learn how TUDCA might transform MS therapy and enhance patient outcomes. 🔗 Dive into the full article here: https://lnkd.in/d4XDNZhR #MultipleSclerosis #BileAcidSupplements #HealthcareInnovation #ICEPharma
-
-
Last week it was held in Lugano (Switzerland) DCAT Sustainability Summit, the first DCAT’s conference and networking event in Europe, which brought high-level executives together to discuss the opportunities, challenges, and value creation opportunities of sustainability in the bio/pharma industry. The conference featured a CEOs Unplugged session which included our Chief Transformation and Sustainability Officer, Luca Sartorello on stage. We had the chance to share with the participants many valuable ideas and insights on sustainability, as well as, explain the experience, vision and commitment of ICE Pharma toward sustainability. Thanks to everyone who joined the conference and share a moment with us!
-